Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Influence of tumour micro-environment heterogeneity on therapeutic response.

Junttila MR, de Sauvage FJ.

Nature. 2013 Sep 19;501(7467):346-54. doi: 10.1038/nature12626. Review.

PMID:
24048067
2.

Stromal fibroblasts in cancer initiation and progression.

Bhowmick NA, Neilson EG, Moses HL.

Nature. 2004 Nov 18;432(7015):332-7. Review.

3.

Role of the host stroma in cancer and its therapeutic significance.

Tarin D.

Cancer Metastasis Rev. 2013 Dec;32(3-4):553-66. doi: 10.1007/s10555-013-9438-4. Review.

PMID:
23625010
4.

Metabolic reprogramming of the tumour microenvironment.

Xing Y, Zhao S, Zhou BP, Mi J.

FEBS J. 2015 Oct;282(20):3892-8. doi: 10.1111/febs.13402. Epub 2015 Aug 25. Review.

5.

The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention?

Mahale J, Smagurauskaite G, Brown K, Thomas A, Howells LM.

Int J Cancer. 2016 Jan 1;138(1):30-44. doi: 10.1002/ijc.29447. Epub 2015 Feb 6. Review.

6.

Understanding the role of stromal fibroblasts in cancer progression.

Tripathi M, Billet S, Bhowmick NA.

Cell Adh Migr. 2012 May-Jun;6(3):231-5. doi: 10.4161/cam.20419. Epub 2012 May 1. Review.

7.

The tumor microenvironment.

Weber CE, Kuo PC.

Surg Oncol. 2012 Sep;21(3):172-7. doi: 10.1016/j.suronc.2011.09.001. Epub 2011 Oct 1. Review.

PMID:
21963199
8.

Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.

Cirri P, Chiarugi P.

Cancer Metastasis Rev. 2012 Jun;31(1-2):195-208. doi: 10.1007/s10555-011-9340-x. Review.

PMID:
22101652
9.

A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis.

Correa de Sampaio P, Auslaender D, Krubasik D, Failla AV, Skepper JN, Murphy G, English WR.

PLoS One. 2012;7(2):e30753. doi: 10.1371/journal.pone.0030753. Epub 2012 Feb 20.

10.

Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?

Puré E, Lo A.

Cancer Immunol Res. 2016 Apr;4(4):269-78. doi: 10.1158/2326-6066.CIR-16-0011. Review.

11.

Bone marrow cells as precursors of the tumor stroma.

Worthley DL, Si Y, Quante M, Churchill M, Mukherjee S, Wang TC.

Exp Cell Res. 2013 Jul 1;319(11):1650-6. doi: 10.1016/j.yexcr.2013.03.006. Epub 2013 Mar 13. Review.

12.

Pten in stromal fibroblasts suppresses mammary epithelial tumours.

Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, Leone G.

Nature. 2009 Oct 22;461(7267):1084-91. doi: 10.1038/nature08486.

13.

Tumor stroma as targets for cancer therapy.

Zhang J, Liu J.

Pharmacol Ther. 2013 Feb;137(2):200-15. doi: 10.1016/j.pharmthera.2012.10.003. Epub 2012 Oct 12. Review.

14.

Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.

van Kempen LC, Leenders WP.

Eur J Cell Biol. 2006 Feb;85(2):61-8. Epub 2005 Nov 11. Review.

PMID:
16439306
15.

Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis.

Kinoshita H, Hirata Y, Nakagawa H, Sakamoto K, Hayakawa Y, Takahashi R, Nakata W, Sakitani K, Serizawa T, Hikiba Y, Akanuma M, Shibata W, Maeda S, Koike K.

PLoS One. 2013 Apr 12;8(4):e60914. doi: 10.1371/journal.pone.0060914. Print 2013.

16.

Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types.

Gandellini P, Andriani F, Merlino G, D'Aiuto F, Roz L, Callari M.

Semin Cancer Biol. 2015 Dec;35:96-106. doi: 10.1016/j.semcancer.2015.08.008. Epub 2015 Aug 28. Review.

PMID:
26320408
17.

Revisiting ovarian cancer microenvironment: a friend or a foe?

Zhang B, Chen F, Xu Q, Han L, Xu J, Gao L, Sun X, Li Y, Li Y, Qian M, Sun Y.

Protein Cell. 2017 Sep 19. doi: 10.1007/s13238-017-0466-7. [Epub ahead of print] Review.

PMID:
28929459
18.

A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.

Clark AK, Taubenberger AV, Taylor RA, Niranjan B, Chea ZY, Zotenko E, Sieh S, Pedersen JS, Norden S, Frydenberg M, Grummet JP, Pook DW; Australian Prostate Cancer BioResource, Stirzaker C, Clark SJ, Lawrence MG, Ellem SJ, Hutmacher DW, Risbridger GP.

Biomaterials. 2013 Jul;34(20):4777-85. doi: 10.1016/j.biomaterials.2013.03.005. Epub 2013 Apr 2.

PMID:
23562048
19.

Stromal contributions to the carcinogenic process.

Spaw M, Anant S, Thomas SM.

Mol Carcinog. 2017 Apr;56(4):1199-1213. doi: 10.1002/mc.22583. Epub 2016 Nov 5. Review.

PMID:
27787930
20.

Targeting tumor stroma: exploiting apoptotic priming.

Mertens JC, Gores GJ.

Oncotarget. 2012 Dec;3(12):1501-2. No abstract available.

Supplemental Content

Support Center